Skip to content

COVID-19 Rapid Test

Early January 2020, a novel coronavirus (2019-nCoV) was identified as the infectious agent causing an outbreak of viral pneumonia in China, where the first cases had their symptom onset in December 2019.

Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals, and birds and that cause respiratory, enteric, hepatic, and neurologic diseases.

Coronaviruses are zoonotic, which means they can be transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, and cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.

COVID-19 Rapid Test

The Spring Health Care COVID19 IgG/IgM Rapid Test Cassette was developed as a 10 minutes simple field test which allows field personnel with minimal training to perform.

The test detects the presence of IgG and IgM antibodies specific to 2019n-CoV (detected in China in 2019) generally available in whole blood / serum / plasma after infection by 2019n-CoV

  • Distributed By Vita Medical Solutions
  • Registered with the FDA
  • Measures Both IgG and IgM Antibodies
  • CE ( European CE Certified )

Results in 10 Min.

Accuracy on IgG 98%, Accuracy on IgM 96%

Zero Cross Reactivity  with Influenza A, Influenza B, Chlamydia, Hepatitis, HIV,  EB, Measles and Mumps*

Designed, and Manufactured in Switzerland / Distributed in the USA by VITA Medical Solutions

*Figures based on independent clinical trial and laboratory testing

Easiest Description of Results

Coronaviruses are zoonotic, which means they can be transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, and cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
IgM
IgG
Clinical Signifcance
Patient may have no active infection or may be in the window period of infection before antibodies are detectable. Recommendation for observation to determine if further testing is necessary approximately one week later.
+
Patient may be in the early stage of infection. This is likely the time a patient is showing symptoms such as fever. Recommendation to assess patient’s current conditions and determine if further action is required. Patient should quarantine for 14 days. Recommended reexamination one week later.
+
+
Patient is in the active phase of infection. patient will likely be showing symptoms. Recommendation to assess patient’s conditions and determine if additional actions, such as sending patient to the hospital is required. patient should quarantine for 14 days. Recommended reexamination one week later.
+
Patient may be in the late or recurrent stage of infection. Patient may have had a previous infection and recovered. Further observation is recommended.

Intended Use

Testing with the COVID19 IgG/IgM Rapid Test Cassette should only be performed in conjunction with other laboratory approved testing and/or clinical observations for the presumptive identification of viral infections in patients who may be infected with 2019nCoV.

All test results are presumptive and should be confirmed by an approved molecular assay.

A presumptive negative test does not preclude 2019n-CoV infection and should not be used as the sole basis for treatment or other patient management decisions. Conversely, a presumptive positive result does not rule out infections caused by other viruses.

Play Video

When Can I Get Tested?

Following FDA and CDC guidelines, we're working to bring to market an at home COVID-19 Test Kit. Get notified as soon as the test is available.